1-Year Impact on Medical Practice and Clinical Outcomes of FFRCT
Manesh R. Patel(Clinical Research Institute), Jonathon Leipsic(University of British Columbia), Niels Peter Rønnow Sand(University of Southern Denmark), Jeroen Sonck(Onze Lieve Vrouwziekenhuis Hospital), Michael Poon(Northwell Health), Bjarne Linde Nørgaard(Aarhus University Hospital), Tomohiro Kawasaki(Koga Hospital), Tetsuya Amano(Aichi Medical University), Campbell Rogers(HeartFlow (United States)), Lynne Koweek(Duke University), Bernard De Bruyne(Onze Lieve Vrouwziekenhuis Hospital), Jeroen J. Bax(Netherlands Heart Institute), Koen Nieman(Stanford University), Mark Rabbat(Loyola University Chicago), Kristian Altern Øvrehus(University of Southern Denmark), Gianluca Pontone(Centro Cardiologico Monzino), Jesper Møller Jensen(Aarhus University Hospital), Gilbert Raff, Hitoshi Matsuo, Timothy Fairbairn(University of Liverpool), Takashi Akasaka(Wakayama Medical University), Daniel S. Berman(Cedars-Sinai Medical Center), Sarah Mullen(HeartFlow (United States))
Cited by 309
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k